[Myelin basic protein stimulation index of CD 2 cells in the course of steroid treatment].
Myelin basic protein CD 2 lymphocyte stimulation index calculated as the proportion of percentage of myelin basic protein stimulated CD 2 lymphocytes to unstimulated CD 2 lymphocytes was evaluated in a group of 23 multiple sclerosis patients in the course of prednisone or methylprednisolone treatment. After both treatments a decrease of myelin basic protein CD 2 lymphocyte stimulation index was observed, statistically significant after methyloprednisolone medication.
Wender
M
M
Zespołu Neuroimmunologicznego Centrum Medycyny Doświadczalnej i Klinicznej PAN w Poznaniu.
Sniatała-Kamasa
M
M
Wójcicka
M
M
Tokarz-Kupczyk
E
E
Losy
J
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000276:immunology; D018801:CD2 Antigens / Q000276:immunology*; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology*; D004676:Myelin Basic Protein / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; D004676:Myelin Basic Protein; D011241:Prednisone; D008775:Methylprednisolone